Get started
Author

Heidi K. Schroeder

Observed names: H. Schroeder, Heidi Schroeder
OpenAlex ID: A5057656830
The Generalized Anxiety Disorder 7-Item Scale in Adolescents with Generalized Anxiety Disorder: Signal Detection and Validation
2017 · Sarah A. Mossman, Marissa J. Luft, et al. · Annals of Clinical Psychiatry · 471
Mega‐analysis methods in ENIGMA : The experience of the generalized anxiety disorder working group
2020 · André Zugman, Anita Harrewijn, et al. · Human Brain Mapping · 81
Escitalopram in Adolescents With Generalized Anxiety Disorder
2020 · Jeffrey R. Strawn, Jeffrey A. Mills, et al. · The Journal of Clinical Psychiatry · 80
Cortical and subcortical brain structure in generalized anxiety disorder: findings from 28 research sites in the ENIGMA-Anxiety Working Group
2021 · Anita Harrewijn, Elise M. Cardinale, et al. · Translational Psychiatry · 68
PDF
Bridging Anxiety and Depression: A Network Approach in Anxious Adolescents
2020 · Eric T. Dobson, Paul E. Croarkin, et al. · Journal of Affective Disorders · 43
Antidepressant Prescribing by Pediatricians: A Mixed-Methods Analysis
2017 · Anne K. Tulisiak, Jillian A. Klein, et al. · Current problems in pediatric and adolescent health care · 30
Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial
2021 · Lu Lu, Jeffrey A. Mills, et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 29
PDF
Acute neurofunctional effects of escitalopram during emotional processing in pediatric anxiety: a double-blind, placebo-controlled trial
2021 · Lu Lu, Hailong Li, et al. · Neuropsychopharmacology · 22
PDF
Gastrointestinal Symptoms in Pediatric Patients with Anxiety Disorders and Their Relationship to Selective Serotonin Reuptake Inhibitor Treatment or Placebo
2023 · W. Thomas Baumel, Jeffrey A. Mills, et al. · Child Psychiatry & Human Development · 14
PDF
Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial
2021 · Jeffrey R. Strawn, Ethan A. Poweleit, et al. · Journal of Personalized Medicine · 13
PDF
Acid-sensing T cell death associated gene-8 receptor expression in panic disorder
2017 · Jeffrey R. Strawn, Lauren L. Vollmer, et al. · Brain Behavior and Immunity · 12
Electronically Monitored Antidepressant Adherence in Adolescents with Anxiety Disorders: A Pilot Study
2024 · Jeffrey R. Strawn, Jeffrey A. Mills, et al. · Journal of Child and Adolescent Psychopharmacology · 7
PDF
Executive Functioning in Pediatric Anxiety and Its Relationship to Selective Serotonin Reuptake Inhibitor Treatment Response: A Double-Blind, Placebo-Controlled Trial
2022 · W. Thomas Baumel, Jeffrey A. Mills, et al. · Journal of Child and Adolescent Psychopharmacology · 7
Circulating endocannabinoids in children and adolescents: associations with anxiety and the impact of selective serotonin reuptake inhibitors
2025 · Hilary A. Marusak, Clara G. Zundel, et al. · Neuropsychopharmacology · 6
The Impact of COVID-19 Infection and Characterization of Long COVID in Adolescents With Anxiety Disorders: A Prospective Longitudinal Study
2023 · Jeffrey R. Strawn, Jeffrey A. Mills, et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 6
PDF
Greater Dynamic and Lower Static Functional Brain Connectivity Prospectively Predict Placebo Response in Pediatric Generalized Anxiety Disorder
2020 · Lu Lu, Hailong Li, et al. · Journal of Child and Adolescent Psychopharmacology · 5
Letter to the Editor: The Impact of Adherence and CYP2C19 Phenotype on Escitalopram Exposure in Adolescents
2024 · W. Thomas Baumel, Ethan A. Poweleit, et al. · Journal of Child and Adolescent Psychopharmacology · 4
PDF
Pediatric anxiety and daily fine particulate matter: A longitudinal study
2022 · Andrew Vancil, Jeffrey R. Strawn, et al. · Psychiatry Research Communications · 4
PDF
5.27 a Randomized, Placebo-controlled Study of Escitalopram in Adolescents With Generalized Anxiety Disorder
2019 · Jeffrey Robert Strawn, Jeffrey A. Mills, et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 3
Brain age prediction in generalized anxiety disorder using a convolutional neural network
2026 · Corey Richier, André Zugman, et al. · Translational Psychiatry · 1
PDF
5.7 Cyp2c19 Metabolizer Status Predicts Escitalopram Pharmacokinetics in Adolescents With Generalized Anxiety Disorder
2019 · Anne K. Tulisiak, Ethan Poweleit, et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 1
2.8 Baseline Executive Function and Its Relationship to Escitalopram Response in Adolescents With Anxiety: A Double-Blind, Placebo-Controlled Trial
2022 · William Thomas Baumel, Jeffrey A. Mills, et al. · Journal of the American Academy of Child & Adolescent Psychiatry
Short-term Ambient Fine Particulate Matter and Anxiety Symptoms in Adolescents with Generalized Anxiety Disorder
2020 · C. Brokamp, S. Mossman, et al. · ISEE Conference Abstracts
3.1 Behavioral Inhibition's Effect on Emotional Processing in Adolescents With Generalized Anxiety Disorder
2020 · William T. Baumel, Jeffrey Robert Strawn, et al. · Journal of the American Academy of Child & Adolescent Psychiatry
1.4 Salience Network Dynamic Functional Connectivity in Adolescents With Generalized Anxiety Disorder
2018 · Marissa J. Luft, Kim M. Cecil, et al. · Journal of the American Academy of Child & Adolescent Psychiatry
Works count: 26
Citation count: 907
H-index: 11
I10-index: 11
Year
Topic
Type